Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2010-022952-22-IT
EUCTR2010-022952-22-IT
Active, not recruiting
Not Applicable

Acetytilcysteine Versus placebo for the prevention of Acute Reduction in Renal function after primary Angioplasty (NoVARA) - NoVARA

AZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA0 sitesDecember 17, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionspatient with ST elevation myocardial acute infarctionMedDRA version: 9.1Level: SOCClassification code 10007541
DrugsFLUIMUCIL UROL.

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
patient with ST elevation myocardial acute infarction
Sponsor
AZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA
Status
Active, not recruiting
Last Updated
12 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 17, 2010
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
AZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA

Eligibility Criteria

Inclusion Criteria

  • •patients with aged 18 years and 90 yearsa dmitted in hospital for acute coronary syndrome with persistente ST elevation and chest pain less than 12 hours
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •shock cardiogenic, chronic dialisis, pregnancy, allergy to N\-acetylcysteine, inability to obtain informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
acetylcysteine as a Preventive Measure for Contrast Induced Nephropathy in Intensive Care Patients with Renal InsufficiencyRenal insufficiencyUrological and Genital Diseases
ISRCTN43635237Academic Medical Centre (AMC) (Netherlands)246
Completed
Not Applicable
se of N-Acetylcysteine for prevention of Heart-Lung machine associated liver complication in cardiac surgery
CTRI/2018/05/014024Dr Ram Manohar Lohia institute of Medical Sciences Lucknow66
Completed
Phase 2
Adjuvant N Acetylcysteine for Post Traumatuic Stress Disorder
ACTRN12618001784202Austin Health105
Completed
Not Applicable
Evaluating N-acetylcysteine efficacy in the prevention of amphotericin B-induced nephrotoxicityFungal infections.Certain infectious and parasitic diseasesB37? B38 ?
IRCT201107233449N8Tehran University of Medical Sciences60
Completed
Not Applicable
Does prophylactic N-AcetylCysteine decrease incidence of contrast nephropathy in patients undergoing peripheral angiography?Contrast induced nephropathyUrological and Genital DiseasesNephropathy
ISRCTN35882618Cambridge University Hospital NHS Trust (UK)40